Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection to Treat Moderate to Severe Glabellar Lines
Clinical trial NCT06937944 · RECRUITING
Trial details
- NCT number
- NCT06937944
- Sponsor
- JHM BioPharma (Tonghua) Co. , Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-30
- Primary completion
- 2026-02-09
- Enrollment
- 669
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.